Synopsis

CMR has a unique role is both acute and chronic ischemic heart disease for its ability to provided in vivo tissue characterisation. The talk will focus how the imaging biomarkers from cine imaging (regional wall motion abnormalities(, edema imaging (acute myocardial injury), first pass perfusion (myocardial ischemia), late enhancement imaging (myocardial and microvascular damage) can be used by the clinician to guide decision making and treatment.